These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29859508)

  • 41. Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment.
    Din JN; Newby DE; Flapan AD
    BMJ; 2004 Jan; 328(7430):30-5. PubMed ID: 14703544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association.
    Kris-Etherton PM; Harris WS; Appel LJ;
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):151-2. PubMed ID: 12588750
    [No Abstract]   [Full Text] [Related]  

  • 43. The utility of omega-3 fatty acids in cardiovascular disease.
    Saremi A; Arora R
    Am J Ther; 2009; 16(5):421-36. PubMed ID: 19092647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omega-3 fatty acids in the prevention-management of cardiovascular disease.
    Simopoulos AP
    Can J Physiol Pharmacol; 1997 Mar; 75(3):234-9. PubMed ID: 9164707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014.
    Rice HB; Bernasconi A; Maki KC; Harris WS; von Schacky C; Calder PC
    Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():30-42. PubMed ID: 26858145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PURLs: should you still recommend omega-3 supplements?
    Monaco J; Mounsey A; Bello Kottenstette J
    J Fam Pract; 2013 Aug; 62(8):422-4. PubMed ID: 24143335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.
    Cicero AFG; Fogacci F; Borghi C
    JAMA Cardiol; 2018 Aug; 3(8):780-781. PubMed ID: 29874376
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Wen YT; Dai JH; Gao Q
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):470-5. PubMed ID: 24472636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply.
    Clarke RJ; Aung T; Armitage J
    JAMA Cardiol; 2018 Aug; 3(8):781-782. PubMed ID: 29874365
    [No Abstract]   [Full Text] [Related]  

  • 50. Have the heart for fish oil?
    Johns Hopkins Med Lett Health After 50; 2008 Sep; 20(7):1-2. PubMed ID: 18822526
    [No Abstract]   [Full Text] [Related]  

  • 51. Reply to the editor.
    Costanzo S; Di Castelnuovo A; Iacoviello L
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):992-3. PubMed ID: 24041166
    [No Abstract]   [Full Text] [Related]  

  • 52. Vitamin D and the heart: why we need large-scale clinical trials.
    Manson JE
    Cleve Clin J Med; 2010 Dec; 77(12):903-10. PubMed ID: 21147944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Supplementation of n-3 polyunsaturated fatty acids to prevent postoperative atrial fibrillation in patients subjected to heart surgery.
    Messori A; Fadda V; Maratea D
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):991-2. PubMed ID: 24041165
    [No Abstract]   [Full Text] [Related]  

  • 54. Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease.
    Nestel P; Clifton P; Colquhoun D; Noakes M; Mori TA; Sullivan D; Thomas B
    Heart Lung Circ; 2015 Aug; 24(8):769-79. PubMed ID: 25936871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary omega-3 fatty acid intake and cardiovascular risk.
    Psota TL; Gebauer SK; Kris-Etherton P
    Am J Cardiol; 2006 Aug; 98(4A):3i-18i. PubMed ID: 16919512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. n-3 Fatty acids and mood: the devil is in the detail.
    Richardson AJ
    Br J Nutr; 2008 Feb; 99(2):221-3. PubMed ID: 17919344
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.
    Chen Q; Cheng LQ; Xiao TH; Zhang YX; Zhu M; Zhang R; Li K; Wang Y; Li Y
    Cardiovasc Drugs Ther; 2011 Jun; 25(3):259-65. PubMed ID: 21626218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are n-3 fatty acids still cardioprotective?
    Harris WS
    Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):141-9. PubMed ID: 23196817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Omega-3 Fatty Acids and Cardiovascular Disease.
    Rogers TS; Seehusen DA
    Am Fam Physician; 2018 May; 97(9):562-564. PubMed ID: 29763262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.